Misoprostol for treating postpartum haemorrhage: A randomized controlled trial [ISRCTN72263357]

BMC Pregnancy and Childbirth

Volumn 4, Issue , 2004, Pages

  Hofmeyr, G Justus ^a   Ferreira, Sandra ^a   Nikodem, V Cheryl ^b   Mangesi, Lindeka ^a   Singata, Mandisa ^a   Jafta, Zukiswa ^a   Maholwana, Babalwa ^a   Mlokoti, Zonke ^c   Walraven, Gijs ^d   Gülmezoglu, A Metin ^e  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WESTERN CAPE   (South Africa)

^c Tembisa Hosp Effective Care Res U   (South Africa)

^d Aga Khan Health Services   (France)

^e World Health Organisation   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ERGOMETRINE PLUS OXYTOCIN; HEMOGLOBIN; MISOPROSTOL; OXYTOCIN; PLACEBO; PLASTIC; TRANEXAMIC ACID;

ADULT; ARTICLE; BLOOD TRANSFUSION; CHILDBIRTH; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; FEMALE; FEVER; HEALTH CARE FACILITY; HUMAN; HYSTERECTOMY; INCIDENCE; INFORMED CONSENT; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; MEDICAL PRACTICE; POSTPARTUM HEMORRHAGE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SHIVERING; SOUTH AFRICA; TREATMENT OUTCOME; UTERUS CONTRACTION;

EID: 12944316296     PISSN: 14712393     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-4-16     Document Type: Article

References (29)

1. Selo-Ojeme DO: Primary postpartum haemorrhage. J Obstet Gynaecol 2002, 22:463-469.
2. Moodley J, for Committee on Confidential Enquiries into Maternal Deaths in South Africa: Saving mothers. Second report on Confidential Enquiries into Maternal Deaths in South Africa 1999-2001. Department of Health, South Africa.
3. Kodio B, de Bernis L, Ba M, Ronsmans C, Pison G, Etard JF: Levels and causes of maternal mortality in Senegal. Trop Med Int Health 2002, 7:499-505.
4. Department of Health, Welsh Office, Scottish Home and Health Department, Department of Health and Social Security: Report of confidential enquiries into maternal deaths in the United Kingdom 1991-1993. HMSO, London 1996.
5. Prendiville WJ, Elbourne D, McDonald S: Active versus expectant management in the third stage of labour (Cochrane Review). In: The Cochrane Library Issue 4 Chichester, UK: John Wiley & Sons, Ltd; 2003.
6. Elbourne DR, Prendiville WJ, Carroli G, Wood J, McDonald S: Prophylactic use of oxytocin in the third stage of labour (Cochrane Review). In: The Cochrane Library Issue 4 Chichester, UK: John Wiley & Sons, Ltd; 2003.
7. McDonald S, Prendiville WJ, Elbourne D: Prophylactic syntometrine versus oxytocin for delivery of the placenta (Cochrane Review). In: The Cochrane Library Issue 4 Chichester, UK: John Wiley & Sons, Ltd; 2003.
8. Mousa HA, Walkinshaw S: Major postpartum haemorrhage. Curr Opin Obstet Gynecol 2001, 13:595-603.
9. Tang OS, Schweer H, Seyberth HW, Lee SWH, Ho PC: Pharmacokinetics of different routes of administration of misoprostol. Human Reproduction 2002, 17:332-336.
10. Norman JE, Thong KJ, Baird DT: Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet 1991, 338:1233-1236.
11. Hofmeyr GJ, Gulmezoglu AM, Alfirevic Z: Misoprostol for induction of labour: a systematic review. Br J Obstet Gynaecol 1999, 106:798-803.
12. Lumbiganon P, Hofmeyr J, Gulmezoglu AM, Pinol A, Villar J: Misoprostol dose-related shivering and pyrexia in the third stage of labour. Br J Obstet Gynaecol 1999, 106:304-308.
13. Gülmezoglu AM, Villar J, Ngoc NN, Piaggio G, Carroli G, Adetoro L, Abdel-Aleem H, Cheng L, Hofmeyr GJ, Lumbiganon P, Unger C, Prendiville W, Pinol A, Elbourne D, El-Refaey H, Schulz KF, for the WHO Collaborative Group To Evaluate Misoprostol in the Management of the Third Stage of Labour: The WHO multicentre double-blind randomized controlled trial to evaluate the use of misoprostol in the management of the third stage of labour. Lancet 2001, 358:689-695.
14. Gülmezoglu AM, Forna F, Villar J, Hofmeyr GJ: Prostaglandins for prevention of postpartum haemorrhage (Cochrane Review). In: The Cochrane Library Issue 4 Chichester, UK: John Wiley & Sons, Ltd; 2003.
15. Abdel-Aleem H, Villar J, Gulmezoglu AM, Mostafa SA, Youssef AA, Shokry M, Watzer B: The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrums after postpartum oral administration. Eur J Obstet Gynecol Reprod Biol 2002, 4419: -4.
16. Chong YS, Chua S, El-Refaey H, Choo WL, Chanrachakul B, Tai BC, Rodeck C, Arulkumaran S: Postpartum intrauterine pressure studies of the uterotonic effect of oral misoprostol and intramuscular syntometrine. Br J Obstet Gynaecol 2001, 108:41-47.
17. McCormick ML, Sanghvi HC, Kinzie B, McIntosh N: Preventing postpartum hemorrhage in low-resource settings. Int J Gynaecol Obstet 2002, 77:267-275.
18. Hofmeyr GJ, Walraven G, Maholwana B, Gülmezoglu AM, Villar J: Misoprostol to treat postpartum haemorrhage: a systematic review of evidence relevant to efficacy, dosage and route of administration. Br J Obstet Gynaecol 2004 in press.
19. Adekanmi OA, Purmessur S, Edwards G, Barrington JW: Intrauterine misoprostol for the treatment of severe recurrent atonic secondary postpartum haemorrhage. Br J Obstet Gynaecol 2001, 108:541-542.
20. Oboro VO, Tabowei TO, Bosah JO: Intrauterine misoprostol for refractory postpartum hemorrhage. Int J Gynecol Obstet 2003, 80:67-68.
21. O'Brien P, El-Refaey H, Gordon A, Geary M, Rodeck CH: Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrine: a descriptive study. Obstet Gynecol 1998, 92:212-214.
22. Ozan H, Bilgin T, Ozsarac N, Ozerkan RK, Cengiz C: Misoprostol in uterine atony: a report of 2 cases. Clin Exp Obstet Gynecol 2000, 27:221-222.
23. Abdel-aleem H, El-Nashar I, Abdel-Aleem A: Management of severe postpartum hemorrhage with misoprostol. Int J Gynecol Obstet 2001, 72:75-76.
24. Shojai R, Piechon L, d'Ercole C, Boubli L, Ponties JE: [Rectal administration of misoprostol for delivery induced hemorrhage. Preliminary study] (French). J Gynecol Obstet Reprod Biol 2001, 30:572-575.
25. Lokugamage AU, Sullivan KR, Niculescu I, Tigere P, Onyangunga F, El Refaey H, Moodley J, Rodeck CH: A randomized study comparing rectally administered misoprostol versus Syntometrine combined with an oxytocin infusion for the cessation of primary post partum hemorrhage. Acta Obstet Gynecol Scand 2001, 80:835-839.
26. Darney PD: Misoprostol: a boon to safe motherhood...or not? Lancet 2001, 358:682-683.
27. Hofmeyr GJ, Gülmezoglu AM: Vaginal misoprostol for cervical ripening and induction of labour (Cochrane Review). In: The Cochrane Library Issue 4 Chichester, UK: John Wiley & Sons, Ltd; 2003.
28. Hofmeyr GJ: Misoprostol in obstetrics and gynaecology - unregistered, dangerous and essential. S Afr Med J 1998, 88: 35-536.
29. Hofmeyr GJ, Nikodem VC, de Jager M, Gelbart BR: A randomised controlled trial of oral misoprostol in the third stage of labour. Br J Obstet Gynaecol 1998, 105:971-975.